DIAGAST
Cédric Gagnepain currently serves as the Responsable Développement Hardware at DIAGAST, focusing on immuno-hématologie and innovations since September 2023. Prior to this role, Cédric Gagnepain was a Chef de projet at Bio-Rad Laboratories from June 2011 to February 2024, leading the development and manufacturing of IVD blood grouping devices, achieving significant milestones including the first IVD instrument in immunology with integrated robotic capabilities. Cédric held the position of Responsable recherche et développement at Croma Pharma France between February 2005 and June 2011, overseeing a team dedicated to creating a modular surgical device for eye surgery, resulting in three patent filings. Cédric began the career as an Ingénieur projets at DMS Imaging from September 1999 to February 2005, specializing in electronics. Cédric's academic background includes a Diplôme de Recherche Technologique in Electronics from Université Montpellier II, a Diplôme d'ingénieur in Micro-electronics and Automation from Polytech Montpellier, and a DUT in Electrical Engineering and Industrial Computing from IUT Le Creusot.
This person is not in any teams
This person is not in any offices
DIAGAST
1 followers
Receiving blood is receiving life. DIAGAST’s goal is to help healthcare professionals transmit life with the help of the best blood group determination technologies. Even though it is not always a matter of life and death, transfusion errors are never acceptable. Over the last 30 years, DIAGAST has developed unparalleled expertise and know-how in the transfusion sector. DIAGAST develops, manufactures and markets reagents (for blood group determination), miniaturized laboratories for manual analysis and automated systems. DIAGAST also ensures the research, manufacturing and marketing of all its products. Moreover, DIAGAST offers a wide range of related services, such as a training center for their automated systems, a hotline and on-site follow-up on automaton calibration. We even make control and measurement tools available over the Internet. DIAGAST is now the worldwide leader in the marketing and development of reagents and instrumentation systems that aim to ensure donor and patient compatibility during blood transfusions.